ABIONYX PHARMA 1.844 € (-0,86 %)
AIRBUS 200.700 € (+1,03 %)
STMICROELECTRONICS 45.005 € (-3,50 %)
ARCELORMITTAL SA 66.880 € (-0,98 %)
CRCAM MORBIHAN CCI 117.980 € (-1,02 %)
SANOFI 74.700 € (-1,31 %)
ASML HOLDING 1 518.000 € (+1,17 %)
PROSUS 36.230 € (-0,62 %)
SARTORIUS STED BIO 190.400 € (+2,09 %)
CELLECTIS 2.820 € (-3,09 %)
KERING 244.400 € (+1,24 %)
SAFRAN 333.600 € (+0,15 %)
LVMH 426.550 € (-1,08 %)
VALNEVA 2.973 € (+2,87 %)
VERALLIA 19.100 € (-1,04 %)
ATOS GROUP 26.040 € (-0,69 %)
COMPAGNIE ODET 1 312.000 € (+0,15 %)
FERRARI GROUP 8.050 € (0,00 %)
GECINA 67.450 € (-0,07 %)
CORBION 21.580 € (-0,64 %)
ICADE 17.440 € (+0,23 %)
SOLUTIONS 30 SE 0.530 € (-1,49 %)
WOLTERS KLUWER 67.260 € (-0,94 %)
ONCODESIGN PM 0.245 € (+2,08 %)
RELX 29.860 € (-0,80 %)
DBT 0.046 € (+3,15 %)
RENAULT 29.580 € (+1,30 %)
BE SEMICONDUCTOR 195.200 € (-3,60 %)
ING GROEP N.V. 32.245 € (+0,44 %)
QUADIENT 12.820 € (-2,29 %)
CSG 16.770 € (+3,07 %)
MEDINCELL 22.600 € (-0,88 %)
BNP PARIBAS ACT.A 103.880 € (-0,63 %)
DEEZER 1.330 € (-0,75 %)
North Atlantic En. 90.050 € (-0,44 %)
VERIMATRIX 0.351 € (+6,69 %)
CRCAM ILLE-VIL.CCI 120.760 € (+1,56 %)
ORANGE 15.370 € (+0,46 %)
CRCAM PARIS ET IDF 114.200 € (-0,02 %)
SBM OFFSHORE 36.780 € (+1,43 %)
V LANSCHOT KEMPEN 67.500 € (0,00 %)
TOTALENERGIES 77.750 € (+0,58 %)
MONCEY (FIN.) NOM. 115.000 € (+0,44 %)
ABN AMRO BANK N.V. 43.300 € (-0,28 %)
LECTRA 21.900 € (+1,39 %)
OVH 14.290 € (-0,28 %)
SPINEGUARD 0.132 € (+21,77 %)
GENSIGHT BIOLOGICS 0.114 € (+7,12 %)
SHELL PLC 40.855 € (+0,73 %)
DASSAULT AVIATION 281.400 € (+2,18 %)
ABIVAX 101.000 € (+3,11 %)
EXAIL TECHNOLOGIES 124.200 € (0,00 %)
THALES 232.700 € (+0,52 %)
CARVOLIX 5.800 € (+0,35 %)
NOVACYT 0.510 € (+3,66 %)
BRUNEL INTERNAT 7.370 € (+0,14 %)
HEINEKEN 73.220 € (+1,33 %)
ASSYSTEM 41.000 € (-0,97 %)
ALTAREA 88.000 € (-0,79 %)
VIRIDIEN 94.000 € (+5,09 %) |
08/09/2026 19:00
BUREAU VERITAS – Nouvelle émission obligataire de 700 millions d'euros à échéance septembre 2027 - final terms (en anglais)MiFID II product governance / Professional investors and eligible counterparties only target market – Solely for the purposes of each manufacturer’s product approval process, the target market assessment in respect of the Notes has led to the conclusion that: (i) the target market for the Notes is eligible counterparties and professional clients only, each as defined in Directive 2014/65/EU (as amended “MiFID II”); and (ii) all channels for distribution of the Notes to eligible counterparties and professional clients are appropriate. Any person subsequently offering, selling or recommending the Notes (a “distributor”) should take into consideration the manufacturers’ target market assessment; however, a distributor subject to MiFID II is responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or refining the manufacturers’ target market assessment) and determining appropriate distribution channels. UK MiFIR product governance / Professional investors and ECPs only target market – Solely for the purposes of the manufacturer's product approval process, the target market assessment in respect of the Notes, has led to the conclusion that: (i) the target market for the Notes is eligible counterparties, as defined in the FCA Handbook Conduct of Business Sourcebook (“COBS”), and professional clients only, as defined in Regulation (EU) No 600/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (“UK MiFIR”); and (ii) all channels for distribution of the Notes to eligible counterparties and professional clients are appropriate. Any person subsequently offering, selling or recommending the Notes (a “distributor”) should take into consideration the manufacturer's target market assessment; however, a distributor subject to the FCA Handbook Product Intervention and Product Governance Sourcebook (the “UK MiFIR Product Governance Rules”) is responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or refining the manufacturer's target market assessment) and determining appropriate distribution channels. PROHIBITION OF SALES TO EEA RETAIL INVESTORS – The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (“EEA”). For these purposes, a retail investor means a person who is one (or both) of: (i) a retail client as defined in point (11) of Article 4(1) of MiFID II; or (ii) a customer within the meaning of Directive (EU) 2016/97, as amended or superseded (“IDD”), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. Consequently, no key information document required by Regulation (EU) No 1286/2014, as amended (the “PRIIPs Regulation”) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation. PROHIBITION OF SALES TO UK RETAIL INVESTORS - The Notes are not intended to be offered, sold, distributed or otherwise made available to and should not be offered, sold, distributed or otherwise made available to any retail investor in the United Kingdom (“UK”). For these purposes, a retail investor means a person who is either one (or both) of the following: (i) not a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("EUWA"); or (ii) not a qualified investor as defined in paragraph 15 of Schedule 1 to the Public Offers and Admissions to Trading Regulations 2024. Consequently, no disclosure document required by the FCA Product Disclosure Sourcebook (“DISC”) for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the UK may be unlawful under DISC and the Consumer Composite Investments (Designated Activities) Regulations 2024. Final Terms dated 7 September 2026BUREAU VERITAS S.A.Legal entity identifier (LEI): 969500TPU5T3HA5D1F11 SERIES NO: 2 Issue of €700,000,000 4.125 per cent. Notes due 9 September 2034 Under the Euro Medium Term Note Programme Issue Price: 99.386 per cent. BofA SECURITIES PART A – CONTRACTUAL TERMSTerms used herein shall be deemed to be defined as such for the purposes of the Conditions set forth in the Base Prospectus dated 11 May 2026 which received approval no. 26-136 on 11 May 2026 from the Autorité des marchés financiers (the “AMF”) and the first supplement to it dated 31 July 2026 which received approval no. 26-301 on 31 July 2026 from the AMF which together constitute a base prospectus (the “Base Prospectus”) for the purposes of Regulation (EU) 2017/1129, as amended (the “Prospectus Regulation”). This document constitutes the Final Terms of the Notes described herein for the purposes of the Prospectus Regulation and must be read in conjunction with such Base Prospectus in order to obtain all the relevant information. The Base Prospectus is available for viewing on the website of the Issuer (https://group.bureauveritas.com) and on the website of the AMF (www.amf-france.org).
PROVISIONS RELATING TO INTEREST (IF ANY) PAYABLE
PROVISIONS RELATING TO REDEMPTION
GENERAL PROVISIONS APPLICABLE TO THE NOTES
RESPONSIBILITYThe Issuer accepts responsibility for the information contained in these Final Terms. Signed on behalf of Bureau Veritas S.A.: Duly authorised by: Bruno Chambriard, Vice President Group Treasurer PART B – OTHER INFORMATION1. ADMISSION TO TRADING
2. RATINGSRatings: The Notes to be issued have been rated: Pursuant to Moody’s definitions, obligations rated "A" are considered upper-medium-grade and are subject to low credit risk. The addition of the modifier "3" indicates a ranking in the lower end of that generic rating category. Moody’s is established in the European Union and registered under Regulation (EC) No 1060/2009 (as amended) (the “CRA Regulation”) and is included in the list of credit rating agencies published by the European Securities and Markets Authority on its website (https://www.esma.europa.eu/credit-ratingagencies/cra-authorisation) in accordance with CRA Regulation. 3. INTERESTS OF NATURAL AND LEGAL PERSONS INVOLVED IN THE ISSUESave as discussed in “Subscription and Sale” in the Base Prospectus, so far as the Issuer is aware, no person involved in the offer of the Notes has an interest material to the offer. The Managers and their affiliates have engaged, and may in the future engage, in investment banking and/or commercial banking transactions with, and may perform other services for, the Issuer and its affiliates in the ordinary course of business. 4. REASONS FOR THE OFFER, ESTIMATED NET PROCEEDS
5. YIELDIndication of yield: 4.217 per cent. per annum The yield is calculated at the Issue Date on the basis of the Issue Price. It is not an indication of future yield. 6. OPERATIONAL INFORMATION
7. DISTRIBUTION
Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière